Switzerland
Gilead Sciences Switzerland Sàrl
General-Guisan-Strasse 8
6300 Zug
Switzerland
Phone: 41 (0)41 580 02 00 41 (0)41 580 02 00
Fax: 41 (0)41 580 02 98
Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead’s office in Zug is responsible for medical, sales and marketing activities for our products in Switzerland.
Relationships with Patient Organizations and NGOs
Gilead provided support to the following patient organizations and NGOs in 2020. The information is correct at the time of writing (May 2021). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here.
| Patient Organisation and NGO | Description of Activity | Amount Funded CHF |
|---|---|---|
| Aids Hilfe Bern | HIV Peer 2 Peer Projekt AIDS Hilfe Bern 2019 - 2021 | 7500 |
| Aids-Hilfe Schweiz | Urgent Action Plan Corona | 15000 |
| Aids-Hilfe Schweiz | Herbst Awareness & Test Campaign 2020 | 7500 |
| Aids-Hilfe Schweiz | Big HIV Awareness and Testing Campaign Fall 2020 | 60000 |
| Association Ose Thérapies | OSE Therapies Grant | 5000 |
| Fachstelle Für Sexuelle Gesundheit Zürich Segz | Checkpoint in discussion | 32500 |
| Fachstelle Für Sexuelle Gesundheit Zürich Segz | Checkpoint Mobile Testing 2019 | 20000 |
| Fachstelle Für Sexuelle Gesundheit Zürich Segz | Mobile testing for migrants | 8800 |
| Fachstelle Für Sexuelle Gesundheit Zürich Segz | Checkpoint Mobile Testing 2020 | 20000 |
| Hopos-Dachverband | Projekt HOPOS 2020-2021 | 10000 |
| Krebsliga Graubünden | Kolorektal-Karzinom Screening Programm CME 2020 | 2000 |
| Life4me.Plus To Fight Aids, Hepatitis C And Tuberculosis | German HIV news service 2020 | 7000 |
| Life4me.Plus To Fight Aids, Hepatitis C And Tuberculosis | German HIV news service 2020 | 7000 |
| Positivrat Schweiz | Grant Positivrat activities 2020 | 20000 |
| Swiss Hepa - Schweizer Leberpatienten Verein | Swiss HePa 2019 activities | 8000 |
| Swiss Hepa - Schweizer Leberpatienten Verein | Yearly Sponsoring 2020 | 10000 |
Publication of Clinical Study Results
As of 2020, Gilead discloses clinical study results of newly authorized products in Switzerland by Swissmedic according to the requirements laid out in Art. 71-73 TPO (Ordinance on Therapeutic Products).
Products are listed in alphabetical order.
|
Product |
Active Substance |
Authorization Number |
Date of Authorization |
|---|---|---|---|
|
Autologous anti-CD19-transduced |
67884 |
25.08.2021 |
|
|
Sacituzumab govitecan |
68179 |
09.09.2021 |
|
|
Remdesivir |
68026 / 68043 |
25.11.2020 |
This page is intended for visitors outside of the United States.